Urolithin A is produced by some gut microbiomes from ellagitannin-related compounds and is studied for mitochondrial quality control and muscle outcomes. Ergothioneine is obtained directly from food and concentrated through SLC22A4. Human trials exist for both, but address different outcomes and remain limited.
Quick comparison
| Attribute | L-Ergothioneine | Urolithin A |
|---|---|---|
| What it is | Diet-derived sulfur-containing histidine derivative | Gut-microbiome-derived metabolite |
| Main biological role | Transported accumulation and cytoprotective chemistry | Mitophagy and mitochondrial quality-control research |
| How humans obtain it | Directly from foods and supplements | Microbial conversion from food precursors or direct supplementation |
| Primary research areas | Oxidative stress, cognition and aging | Muscle endurance, mitochondrial biomarkers and physical function |
| Human evidence maturity | Emerging across several small outcome areas | Several short randomized trials with mixed primary outcomes |
| Food-source issue | Content varies by species and preparation | Natural conversion differs substantially among individuals |
| Typical supplement context | Dietary antioxidant products | Postbiotic mitochondrial or muscle-aging products |
| Key distinction | Selective uptake through SLC22A4 | Microbiome-linked metabolite studied as a mitophagy activator |
What is L-ergothioneine?
Ergothioneine is absorbed from food and concentrated through SLC22A4. Researchers study its retention, antioxidant chemistry and aging-related associations.
It is present directly in foods rather than requiring microbiome conversion, although exposure can still vary.
Start with the core guide: What is L-ergothioneine?
What is Urolithin A?
Urolithin A is produced by some microbiomes after exposure to ellagitannin- and ellagic-acid-related compounds in foods such as pomegranate and walnuts.
Because conversion varies, trials often administer urolithin A directly and examine mitochondrial gene expression, muscle endurance and physical function.
How their mechanisms differ
Urolithin A research emphasizes mitophagy—the selective recycling of dysfunctional mitochondria. Ergothioneine research emphasizes uptake, retention and protection under oxidative stress.
Ergothioneine is not a direct substitute for an intervention studied as a mitophagy activator, and urolithin A is not an ergothioneine-like transporter substrate.
What the human evidence shows
Ergothioneine has observational and small intervention studies across cognition, sleep, skin and other outcomes.
A 66-person urolithin A trial did not significantly improve its primary 6-minute-walk or maximal-ATP-production endpoints, but reported secondary endurance and biomarker signals.
An industry-sponsored 88-person trial reported strength and endurance signals but did not improve its primary peak-power endpoint. A recent synthesis characterized the randomized literature as small, short and heterogeneous.
Why people compare them
Both are marketed in healthy-aging and cellular-resilience contexts and both are linked to food.
The useful distinction is oxidative/cellular-protection research versus mitochondrial quality-control and muscle-function research.
Can they be taken together?
No robust human evidence establishes that the combination produces additive mitochondrial, muscle or aging benefits.
Mechanistic complementarity is a hypothesis, not an outcome. Product and medical questions require context-specific review.
See the site’s separate safety and side-effects guide.
Which has stronger human evidence?
Urolithin A has more direct randomized research for muscle endurance, physical performance and mitochondrial biomarkers.
Several trials missed important primary endpoints, so more direct does not mean conclusive. Ergothioneine has a broader but earlier evidence base.
Who might be researching each one?
A reader focused on muscle aging, mitochondrial quality control or microbiome-dependent production may encounter urolithin A.
A reader focused on dietary ergothioneine, mushrooms, SLC22A4 or aging-related blood levels may encounter ergothioneine.
Key takeaways
- Urolithin A is microbiome-derived; ergothioneine is consumed directly.
- Mitophagy is central to urolithin A; selective uptake is central to ergothioneine.
- Urolithin A has more direct muscle trials, but several primary outcomes were not significant.
- Natural urolithin A production varies among individuals.
- No combination advantage has been established.
Frequently asked questions
Is urolithin A found directly in pomegranate?
Pomegranate provides precursors; urolithin A is generally produced after microbial metabolism.
Is ergothioneine a mitophagy activator?
It is not established as the same kind of direct mitophagy intervention studied in urolithin A trials.
Which has more muscle research?
Urolithin A has more direct randomized research on muscle and physical performance.
Did urolithin A trials meet every primary endpoint?
No. Important trials reported secondary signals while missing one or more primary outcomes.
Does either compound slow human aging?
Current evidence does not establish that either slows the overall human aging process.
Evidence and references
- Gründemann et al. Discovery of the ergothioneine transporter (PNAS, 2005; PMID 15795384) ↗
- Tian et al. Ergothioneine and healthy ageing (British Journal of Nutrition, 2023; PMID 38018890) ↗
- Liu et al. Urolithin A and muscle endurance: randomized trial (JAMA Network Open, 2022; PMID 35050355) ↗
- Singh et al. Urolithin A in middle-aged adults (Cell Reports Medicine, 2022; PMID 35584623) ↗
- Systematic review of randomized urolithin A muscle trials (2026; PMID 42559151) ↗
Primary papers and major peer-reviewed reviews were checked Oct. 1, 2026. Commercial sources were not used to establish efficacy.
Educational information only. This comparison does not diagnose, treat or provide individualized supplement advice.
Read the full disclaimer →